FDA Clearance Tracker · P020024-S015
AMPLATZER DUCT OCCLUDER AND 180 DEGREE DELIVERY SYSTEM
Last checked: Nov 20, 2026Latest source record: May 3, 2007 (this decision)Source: openFDAMethods & limitations
Decided
May 3, 2007
Approved
Time to decision
181 days
Received Nov 3, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P020024-S015
- Device name
- AMPLATZER DUCT OCCLUDER AND 180 DEGREE DELIVERY SYSTEM
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- Nov 3, 2006
- Decided
- May 3, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P020024
Device type
- Device type
- OCCLUDER, PATENT DUCTUS, ARTERIOSUS (MAE)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE REVISED POST-APPROVAL STUDY.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.